Mixed connective tissue disease surgery: Difference between revisions
No edit summary |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
In MCTD, [[Surgery|surgical]] options are the alternative for the patients who continue to progress in the disease related [[Complication (medicine)|complications]] despite aggressive therapy. The [[Surgery|surgical]] options include procedures like [[atrial septostomy]] and [[lung transplantation]]. | |||
==Surgery== | ==Surgery== | ||
| Line 14: | Line 15: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Rheumatology]] | |||
Latest revision as of 13:45, 20 April 2018
|
Mixed connective tissue disease Microchapters |
|
Differentiating Mixed connective tissue disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mixed connective tissue disease surgery On the Web |
|
American Roentgen Ray Society Images of Mixed connective tissue disease surgery |
|
Directions to Hospitals Treating Mixed connective tissue disease |
|
Risk calculators and risk factors for Mixed connective tissue disease surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
In MCTD, surgical options are the alternative for the patients who continue to progress in the disease related complications despite aggressive therapy. The surgical options include procedures like atrial septostomy and lung transplantation.
Surgery
- In MCTD, surgical options are the alternative for the patients who continue to progress in the disease related complications despite aggressive therapy.
- The surgical options include procedures like atrial septostomy and lung transplantation.[1]
References
- ↑ Ciang NC, Pereira N, Isenberg DA (March 2017). "Mixed connective tissue disease-enigma variations?". Rheumatology (Oxford). 56 (3): 326–333. doi:10.1093/rheumatology/kew265. PMID 27436003.